| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.778 | 13.281 | 0 | 0 | 0 | 0 | 0 | 42.282 | 106.058 | 119.955 |
| Total Income - EUR | 22.219 | 15.093 | 0 | 0 | 0 | 0 | 0 | 42.674 | 106.080 | 120.191 |
| Total Expenses - EUR | 25.983 | 17.001 | 0 | 0 | 0 | 0 | 0 | 41.544 | 105.511 | 123.168 |
| Gross Profit/Loss - EUR | -3.764 | -1.908 | 0 | 0 | 0 | 0 | 0 | 1.130 | 568 | -2.977 |
| Net Profit/Loss - EUR | -4.430 | -2.313 | 0 | 0 | 0 | 0 | 0 | 1.044 | -492 | -5.474 |
| Employees | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 |
Check the financial reports for the company - Abiespharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 770 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 8.172 | 4 | 0 | 0 | 0 | 0 | 0 | 24.547 | 25.410 | 39.624 |
| Inventories | 6.764 | 0 | 0 | 0 | 0 | 0 | 0 | 20.264 | 18.580 | 30.234 |
| Receivables | 901 | 0 | 0 | 0 | 0 | 0 | 0 | 1.661 | 4.568 | 3.422 |
| Cash | 507 | 4 | 0 | 0 | 0 | 0 | 0 | 2.622 | 2.262 | 5.968 |
| Shareholders Funds | -4.114 | -6.385 | 0 | 0 | 0 | 0 | 0 | 1.084 | 589 | -4.889 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.056 | 6.389 | 0 | 0 | 0 | 0 | 0 | 23.463 | 24.821 | 44.513 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Abiespharm Srl